| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |